ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
16/02/2024
Voltar para busca
Dado oficial do USPTO
AGEPHA PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AGEPHA PHARMA
ST13
US500000079316388Classe
3, 5, 44
Pedido
79316388
Registro
6810899
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
16/02/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 44
Data de depósito
14/04/2021
Data de registro
09/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/08/2022
Última transação
09/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
NOBLE, ANNIE MELISSA
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Murray & Poole Enterprises Ltd
A. S. (pessoa física)
Representantes
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Laundry preparationslaundry detergent and laundry bleaching preparations
Classe 5
Pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical products for the treatment and viral and infectious diseasesfor the treatment of cancer; pharmaceutical preparations for the treatment of hormonal disorders at the prevention of osteoporosis; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for skin care; pharmaceutical preparationsappetite suppressants; pharmaceutical preparationsantidepressants; pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceuticalsanti-infectives; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and/or treatment of hard diseases; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculo-skeletalcardiovascularcardiopulmonarygenitourinarysexual disfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastro intestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medical preparations for the prevention and treatment of eye diseases; sanitary sterilizing preparations; sanitary preparations for medical purposes; dietary nutritional supplements and dietetic preparations in the nature of food and beverages adapted for medical use; infant formula; nutritional supplements; Plasters for medical purposes; materials for dressingsgauze for dressings; medical dressings; medical plasters; disinfectants soaps and antiseptics; eye drops; eye baths in the nature of saline wash for medical purposes; collyrium; medicated eye-washes; ocular pharmaceuticals; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention of ocular diseases; pharmaceutical preparations for the prevention of ocular disorders; medicinal healthcare preparations for stimulating hair growth; therapeutic medicated bath preparations; tisanes; food supplements for non-medical purposes; disinfectants for medical instruments; dietetic foods adapted for medical purposes; eye bandages for medical use; eye pads for medical use; medicated and sanitising soaps and detergents; dental preparations for disclosing plaque and medicated dentifrices; cardiovascular pharmaceutical preparations; cardiovascular treatment pharmaceuticals
Classe 44
Medical services; health care consultancy services; Medical consultancy and medical information services relating to the field of the use of medical products; health counselling; human healthcare serviceswellness programs; human hygiene and beauty care; optometric services
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
09/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/11/2022
FIMP
FINAL DISPOSITION PROCESSED
18/11/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
24/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/05/2022
PUBO
PUBLISHED FOR OPPOSITION
24/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
20/04/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/04/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
20/04/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/03/2022
RFNT
REFUSAL PROCESSED BY IB
30/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2022
RFRR
REFUSAL PROCESSED BY MPU
12/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/12/2021
CNRT
NON-FINAL ACTION WRITTEN
17/12/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AGEPHA PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.